TopRight submits public bids for shares and warrants in ChromoGenics

Report this content

TopRight Nordic AB (publ) has today, March 3, 2021, submitted a ‘’public bid offer to the shareholders and warrant holders of the TO3 series’’ in ChromoGenics AB.

The board of ChromoGenics intends to comment on the offer in a separate order.

For more information, please contact:
Johan Hedin, Chairman of the board, +46 (0) 211 08 56
Leif Ljungqvist, CEO: +46 (0) 70 594 94 01
Lars Ericsson, CFO & Head of Communications: +46 (0)18 430 0430

This statement has been made in a Swedish and English version. In the event of any discrepancies between the Swedish and English text, the Swedish text shall prevail.

About ChromoGenics
ChromoGenics offers dynamic glass that controls the conveyance of heat and light. The company’s unique ConverLight™ technology offers sustainable solar protection for increased indoor comfort and energy efficiency. ConverLight® also helps properties meet environmental certification. Commercial sales to real estate projects in Scandinavia began in 2016.

ChromoGenics is based in Uppsala and is a spin-off from the world-class research at the Ångström Laboratory at Uppsala University. The company’s production facilities have been financed in part by a conditional loan from the Swedish Energy Agency. ChromoGenics’ share (CHRO) is listed on Nasdaq First North Growth Market, and Erik Penser Bank AB is the Certified Adviser.


Documents & Links